Lance Baldo, MD

Adaptive Biotechnologies
Seattle, Washington, United States

Adaptive Biotechnologies (Employee, Shareholder, Leadership Interest)

Presentation(s):

• 126 - Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection and Vaccination

  On Demand

• 144 - Clinical Validation and Performance of a T-cell Immunosequencing Assay to Identify Past SARS-CoV-2 Infection

  On Demand

• LB17 - Immunosequencing of the T-Cell Receptor Repertoire Reveals Signatures Specific for Diagnosis and Characterization of Early Lyme Disease

  Saturday, October 2, 2021
  1:15 PM - 3:00 PM EDT